Ignite Creation Date:
2024-05-06 @ 7:06 AM
Last Modification Date:
2024-10-26 @ 11:45 AM
Study NCT ID:
NCT02477670
Status:
COMPLETED
Last Update Posted:
2020-09-16
First Post:
2015-06-18
Brief Title:
Efficacy Safety and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia
Sponsor:
Avanir Pharmaceuticals
Organization:
Avanir Pharmaceuticals
Organization Data
Organization:
Avanir Pharmaceuticals
Class:
INDUSTRY
Study ID:
15-AVP-786-202
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Avanir Pharmaceuticals
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None